(RTTNews) - Genentech, a member of the Roche Group (RHHBY), announced new positive data from Stage 2 and Stage 3 of the National Institutes of Health (NIH)-sponsored Phase III OUtMATCH study ...
Stacey Allerton was walking up her stairs to bed when she heard a snap. Collapsing to the ground, she had no idea what had happened. In the emergency department soon afterwards, she described to ...
The phase 1 study tested autogene cevumeran (BNT122, RO7198457), a therapeutic mRNA cancer vaccine developed and researched through a collaboration between BioNTech, an immunotherapy company, and ...
As part of a joint investment with Northern, the new wheel lathe at the Allerton TrainCare Centre will make train maintenance more efficient. The machine, affectionately named ‘Tina’, after the Proud ...
A NEW wheel lathe named Tina has been unveiled at Allerton TrainCare Centre in Merseyside. The machine, which is part of an £8.9 million project between Network Rail and Northern, is designed to ...
THE head of an Allerton primary school has urged Bradford Council to create a pedestrian crossing on a road where two pupils have recently been hit by cars. Michelle Blanchard, head of Beckfoot ...
Michelle Blanchard, of Beckfoot Allerton Academy, told a meeting of councillors in Bradford that the crossroads used by many children to get to and from school was "so dangerous". A petition ...
*Estimated payments are calculated by Cars.com and are for informational purposes only. We’ve estimated your taxes based on your provided ZIP code. These estimates do not include title ...
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a New Drug Application (NDA) for ...
FDA Approves Genentech’s Evrysdi Tablet as First and Only Tablet for Spinal Muscular Atrophy (SMA)
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved a ...
Credit: MirageC via Getty Images. Roche’s subsidiary Genentech has shared positive Phase III data with the US Food and Drug Administration (FDA) as the company targets the billion-dollar lupus market ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug Administration (FDA) has approved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results